---
title: "CardioPrecision moves into US market"
date: "2023-07-27T13:39:50.000Z"
publishedDate: "27 juillet 2023"
summary: "CardioPrecision, a developer of less invasive treatment solutions for structural heart disease, has announced its entry into the US market. The company’s technology was used for endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) for the first time in the USA during a procedure at Massachusetts General Hospital, Boston, USA, a development that [&#8230;] The post CardioPrecision moves into US market appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/cardioprecision-us-market/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-07-27-cardioprecision-moves-into-us-market"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/07/CardioPrecision-cover.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cardioprecision-us-market/"
---

![CardioPrecision moves into US market](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/07/CardioPrecision-cover.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cardioprecision-us-market/*

## L’essentiel

CardioPrecision, a developer of less invasive treatment solutions for structural heart disease, has announced its entry into the US market. The company’s technology was used for endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) for the first time in the USA during a procedure at Massachusetts General Hospital, Boston, USA, a development that [&#8230;] The post CardioPrecision moves into US market appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/cardioprecision-us-market/
